Home | Back to newsletter main page
Case Comprehensive Cancer Center Newsletter

January 12, 2009


Health briefs
The Plain Dealer - cleveland.com, OH - Jan 6, 2009
Dr. Sanford Markowitz, a cancer genetics expert at UH, helped develop the technology behind the stool DNA test, versions of which have been or are being ...

Second Opinion Should Patients Be Told of Better Care Elsewhere?
New York Times, United States - Jan 5, 2009
Dr. Robert J. Weil, a neurosurgeon at the Cleveland Clinic, argued that although it might seem a good idea to inform patients of differences in outcomes ...


Drs. Nathan Berger and Joseph Nadeau have accepted an invitation to speak at the NCI-Mouse Models of Human Cancers Consortium (MMHCC) Steering Committee Business Meeting on January 12, 2009 in San Francisco, CA.

Titles for the presentations are:
Diet Induced Metabolic Disease and Cancers in Genetically-Predisposed Mice
Joseph Nadeau, PhD and Nathan A. Berger, MD

Transdisciplinary Research on Energetics and Cancer Centers: Goals and Progress
Nathan A. Berger, MD


Dr. Joseph Nadeau, was recently named as a Fellow by the American Association for the Advancement of Science (AACS) in the Section of Biological Sciences. Fellow are elected by their peers as recognition of meritorious efforts to advance science or its applications. All Fellows will be recognized for their contributions to science and technology at the Fellows Forum on February 14, 2009 during the AAAS Annual Meeting in Chicago.

MARK YOUR CALENDARS- Farewell Party for Dr. Joanna Brell

Save the date for an event to wish Dr. Joanna Brell all the best in her new role at the National Institutes of Health. A party in her honor is planned for January 23. A formal invitation will be issued with details this week.

We give special thanks to Dr. Brell for her dedicated and capable service as Chair of the Case CCC Protocol Review and Monitoring Committee for the past year. In addition to that role, Dr. Brell has been an active faculty member in the Division of Hematology/Oncology for 7 years. She will be missed!


Last week's Case CCC Scientific Series kickoff was quite a success. Attended by over 60 researchers and graduate students, the first session highlighted the progress of three recipients of Cancer Center pilot funds for imaging projects. Drs. Susann Brady-Kalnay, Chris Flask, and Yanming Wang presented their research progress. Dr. Brady-Kalnay was congratulated for her successful R01 application resulting from her work. Discussions following each of the presentations were engaging and the presenters commented that these discussions will lead to new collaborations. To view photos of the event, please click here.

The Scientific Series will continue its focus on the progress of the Cancer Center's recipients of pilot project funding, with another seminar scheduled for April 16. Announcements with details will be sent soon.

FUNDING OPPORTUNITY– Ohio Cancer Research Associates

The Ohio Cancer Research Associates are accepting applications for research grant funding. Seed money grants awarded by Ohio Cancer Research Associates are made to support research activities broadly related to cancer and leukemia. The organization seeks to fund research that will lead to continued support at the national level.

Full professors or their equivalent are not eligible. Only tenure track, junior faculty or equivalent scientific staffs are generally considered as appropriate. Postdoctoral fellows, research associates, research assistants, and graduate students are ineligible to apply as PIs, but they may be included as support staff. The PI must show evidence of independence; however, applicants must be within six years of their first independent research or faculty appointment. Well established investigators should not submit projects related to their current area of research.

Investigators previously funded by Ohio Cancer Research Associates must provide justification that this application is significantly different from the previously funded project. Information regarding the results of the previously funded proposal and the PI's success in obtaining further national funding must also be provided.

Deadline: February 20

For more information, please click here.

FUNDING OPPORTUNITY– National Science Foundation Partnerships for International Research and Education (PIRE)

The National Science Foundation (NSF) recently published its third biennial call of its flagship international initiative "Partnerships for International Research and Education" (PIRE). PIRE funds US universities to establish (or strengthen) international collaborations for research and education with world-leading overseas universities and research groups. The goal is principally to push forward frontier research and to help the US develop a globally literate and engaged scientific workforce. They suggest that you to look to UK universities for partners who have excellence in science, technology, innovation, and education.

NSF is seeking to fund projects that meet all three of the following objectives:

i) Advance the frontiers of research through international collaboration;

ii) Promote educational excellence via international collaboration; and

iii) Develop partnerships that strengthen the capacity of US institutions for international collaboration.

Deadline: February 26

For more information, please click here.

MARK YOUR CALENDARS– Weekly Seminar Series on Applied Biostatistics in Clinical Research

Mark Schluchter, PhD will be teaching a weekly seminar series on Applied Biostatistics in Clinical Research, sponsored by W.T. Dahms Clinical Research Unit and the Cleveland Clinical and Translational Sciences Collaborative (CTSC). The seminars will run Mondays from 4:00 pm - 5:30 pm in School of Medicine E501, January 12– March 9.

Online registration is open. To register and for more information, click here. For questions about the course, please contact Dr. Schluchter at mds11@case.edu.


**All events are open to anyone interested in attending

January 12

Hematology/Oncology Research In Progress Seminar cancelled

Case CCC Basic Science Faculty Candidate Seminar
Hongwu Zheng, PhD
Research Fellow
Dana Farber Cancer Institute/ Harvard Medical School
Topic: Understanding Glioma Pathogenesis
4:00 pm WRB 1402
This seminar is presented by the Case CCC along with the Departments of Biochemistry, Molecular Biology & Microbiology, and Pharmacology

January 13

January 14

Grand Rounds
John Atkinson, MD
Professor, Medicine- Rheumatology
Professor, Molecular Microbiology
Washington University
Topic: Hemolytic Uremic Syndrome
8:00 am Lerner Tower B-151

CSCRM Seminar
Horst von Recum, PhD
Assistant Professor, Biomedical Engineering
Paul Tesar, PhD
Research Associate, Genetics
Topic: A Primer on Induced Pluripotent Stem (iPS) Cells and How We Move Forward in Cleveland
4:30 pm WRB 1413

January 15

Taussig Cancer Center Core Curriculum Series
Kandice Marchant, MD
Taussig Cancer Center
Cleveland Clinic
Topic: Coagulation Physiology and Basic Coagulation Tests
12:00 pm R3/002 Cleveland Clinic

Case CCC Basic Science Faculty Candidate Seminar
Sang-Oh Yoon, PhD
Research Fellow, Cell Biology
Harvard Medical School
Topic: RanBP3: A Link Between Signaling and Nuclear Transport
3:00 pm W203 Rottman Room

TREC Seminar
Carolyn Ivers-Landis, PhD
Topic: TBA
4:00 pm BRB 732

January 16

Cancer Center Seminar Series/ Blood Club cancelled

Hematology/ Oncology Fellows Seminar
Gregory Chipman, MD
Fellow, Div. of Hem/Onc
Topic: Pseudomyxoma Peritonei
8:00 am Wearn 137

Taussig Cancer Institute Grand Rounds
Peter Sheng, MD
Cincinnati, OHIO
Topic: TBA
8:00 am R3/002-003 Cleveland Clinic

Cell Biology
Alan Tartakoff, PhD
Professor, Pathology
Topic: Novel Genetic Selections and Zygote Formation: Two Fascinations
10:00 am NC1-202 Cleveland Clinic

Pathology Research Seminar Series
Randy Nesse
Topic: New Evolutionary Applications in Medicine
12:00 pm WRB 1413

Case CCC Basic Science Faculty Candidate Chalk Talk
Sang-Oh Yoon, PhD
Research Fellow, Cell Biology
Harvard Medical School
Topic: Regulation of mTOR Signaling Pathway
2:00 pm W203 Rottman Room


For a complete listing of LRI seminars click here.



Emerging Trends in Cancer Immunotherapy
February 18
Holiday Inn, Independence
Course Directors: Drs. Henry Koon, Joseph Baar, Andrew Sloan
Brochure and Registration

Family-Centered Care
March 21
Holiday Inn, Independence
Details to follow

Ohio Collaborative Conference on Bioinformatics (OCCBIO)
June 15 - 17
CWRU campus
For details, click here.

Annual Breast Cancer Update: Highlights of the National Meetings
June 19
Marriott Cleveland East, Warrensville Heights
Details to follow

Case CCC Scientific Retreat 2009
July 10-11
Details to follow

**For more information on these symposiums, please contact Christine Rhoads.


Enrollment is currently open for the following Cancer Biology courses: David Danielpour, PhD will be teaching Basic Cancer Biology and the Interface with Clinical Oncology: PHRM 520/ PATH 520, a graduate-level introductory course in cancer biology taught through the Departments of Pharmacology and Pathology. This course will give students a broad overview of current basic cancer biology, highlight recent advances in cancer therapeutics, and provide a clinical perspective of the pathogenesis and treatment of common cancers. Drs. Danielpour and Joseph Bokar, MD, PhD will be teaching Clinical Interface to Cancer Biology Conference PHRM521/ PATH521, a conference-based enrichment course of PHRM 520/PATH520, taken concurrently with PHRM520/ PATH520 or the following Spring Semester.

Details can be found at:
PHRM520/ PATH520 Course Overview
PHRM520/ PATH520 Class Schedule
PHRM521/ PATH521Course Overview

CALL FOR PAPERS– Ohio Collaborative Conference on Bioinformatics (OCCBIO)

The 4th Annual Ohio Collaborative Conference on Bioinformatics (OCCBIO 2009) will be held at CWRU June 15-17, 2009. The conference provides an interdisciplinary forum for the discussion of methods, research findings, and experiences in the area of Bioinformatics and Computational Biology. An important goal of the conference is to foster long-term collaborative relationships and networking opportunities within the domain of computational approaches to biology that benefit Ohio.

OCCBIO invites researchers in the broad area of bioinformatics to submit their unpublished work to the conference. The conference proceedings will be indexed.

Papers will be accepted through January 27.

For details, please click here.

FUNDING OPPORTUNITY– James S. McDonnell Foundation

The Foundation offers Collaborative Activity Awards to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems.

In each case the focus of the collaborative activity must meet the program guidelines for one of the following program areas:
–Bridging Brain, Mind, and Behavior
–Studying Complex Systems
–Brain Cancer Research

Applications are continuously accepted for these awards.

For more information, please click here.

MARK YOUR CALENDARS–2nd Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science

March 16–18, 2009
Bethesda North Marriott Hotel & Conference Center
Bethesda, MD

Human biospecimens are the foundation of the translational research that will transform patient care. The 2009 BRN Symposium: Advancing Cancer Research Through Biospecimen Science will focus on the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine. This promises to be a stimulating and informative three-day event that will feature interactive discussions and presentations about biospecimen quality and recent advances in biospecimen science.

Abstract Submission Deadline: February 9
Registration Deadline: February 17

For more information, please click here.


Goldhirsh Foundation Brain Tumor Research Awards Program
Initial Proposal Deadline: January 13
Full Proposal Deadline (invite only): April 21

Ovarian Cancer Research Program (OCRP)
Pre-Application Deadline: January 13
Application Deadline: January 27

AACR Career Development Awards for Pediatric Cancer Research
Deadline: January 13

ASCO Cancer Foundation IDEA Grants
Deadline: January 14

UICC Yamagiwa-Yoshida Memorial International Study Grants
Deadline: January 15

NIH Director's New Innovator Awards
Deadline: January 15

Komen/ ASCO Loan Repayment Program
Deadline: January 15

American Institute for Cancer Research Investigator Initiated Grants (IIG)
Deadline: February 16

American Institute for Cancer Research Post-Doctoral Grant Awards (PDA)
Deadline: February 16

American Institute for Cancer Research Matching Grants (MG)
Deadline: February 16

AACR Stand Up To Cancer
LOI Deadline: January 22
Application Deadline (invite only): May 15

ASCO Cancer Foundation Translational Research Professorship
Deadline: January 22

Ovarian Cancer Research Program (OCRP)
Deadline: January 27

Pfizer Oncology Clinical Fellowship Awards
Deadline: January 31

Pfizer Fellowship In Health Disparities
Deadline: January 31

Pfizer Visiting Professorships in Oncology
Deadline: January 31

Jane Coffin Childs Memorial Fund
Deadline: February 1

Albert Lasker Basic Medical Research Award
Deadline: February 2

Lasker-DeBakey Clinical Medical Research Award
Deadline: February 2

Lasker-Koshland Special Achievement Award in Medical Science
Deadline: February 2

Komen/ASCO Medical Student Rotation
Deadline: February 20

Komen/ASCO Resident Travel Award
Deadline: February 20

2009 NASA Space Radiation Summer School
Deadline: February 28

NCI Short-Term Scientist Exchange Program
Deadline: Open

NIH Bulletin – Notices and Funding Opportunities

Revisions to Research Objectives in PA-08-267, Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) (NOT-CA-09-008)

Pre-Application Meeting for RFA-CA-09-010 Genome Characterization Centers and Genome Data Analysis Centers for The Cancer Genome Atlas Research Network (TCGA)[U24] (NOT-CA-09-012)

Genome Characterization Centers and Genome Data Analysis Centers for The Cancer Genome Atlas Research Network (TCGA)[U24] (RFA-CA-09-010)

Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) (PA-07-022)

Exploratory Grants for Behavioral Research in Cancer Control (R21) (PA-06-351)

Produced by:
Gillian Irwin
11100 Euclid Avenue, Wearn 152
Cleveland, Ohio 44106-5065
216-844-8317 phone
216-844-7832 fax

Janice Hassinger
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216-844-1862 phone
216-844-7832 fax


If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to gillian.irwin@case.edu.

If you have trouble viewing this page, click here to view the newsletter online on our website.